Will Higher Sales but Lower Profits Reshape Andersons' (ANDE) Earnings Narrative?

Simply Wall St.
Aug 08
  • The Andersons, Inc. recently announced its second quarter 2025 results, reporting sales of US$3.14 billion, up from US$2.80 billion a year earlier, while net income declined to US$7.86 million from US$35.98 million in the prior year.
  • Despite higher sales, the significant drop in earnings and earnings per share points to ongoing margin pressures affecting overall profitability.
  • We’ll explore how this combination of higher revenue and weaker profit shapes Andersons’ longer-term investment outlook.

These 19 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

Advertisement

Andersons Investment Narrative Recap

To own shares of Andersons, investors need confidence that the company can convert large-scale agribusiness and ethanol operations into consistent earnings growth, despite exposure to commodity and regulatory cycles. The recent Q2 results, showing higher sales but significantly reduced net income, bring margin pressure into focus but do not materially change the biggest short-term catalyst, full control of ethanol assets and potential regulatory tailwinds, or the chief risk, which is ongoing earnings volatility in core grain and renewables segments. The most relevant recent announcement was Andersons' completion of its ethanol plant acquisition, which aligns with its push to capture regulatory benefits from low-carbon fuel policies. However, Q2’s lower profits illustrate that these investments have yet to offset margin compression, showing the ongoing challenge of translating volume and ownership gains into bottom-line stability. But while the ethanol opportunity remains, investors should be aware of the contrasting risk that persistent margin pressure could...

Read the full narrative on Andersons (it's free!)

Andersons' narrative projects $13.3 billion revenue and $186.7 million earnings by 2028. This requires 4.8% yearly revenue growth and a $106.1 million earnings increase from $80.6 million today.

Uncover how Andersons' forecasts yield a $46.67 fair value, a 29% upside to its current price.

Exploring Other Perspectives

ANDE Community Fair Values as at Aug 2025

Five Simply Wall St Community fair value estimates for Andersons range widely, from US$18.52 to US$59.24 per share. While some see upside, recent earnings volatility reminds you to weigh both short-term risks and longer-term potential before deciding.

Explore 5 other fair value estimates on Andersons - why the stock might be worth 49% less than the current price!

Build Your Own Andersons Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

  • A great starting point for your Andersons research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free Andersons research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Andersons' overall financial health at a glance.

Searching For A Fresh Perspective?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

  • AI is about to change healthcare. These 26 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • The end of cancer? These 25 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
  • Rare earth metals are the new gold rush. Find out which 25 stocks are leading the charge.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10